BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
RSS Headlines
Fool UK
Recs
Will rise during next pandemic flu. When will that happen? I have no idea, but at this cheap price, it's not that hard to wait.